SCHEMBL30546134

SCHEMBL30546134

COP(=O)(OC)C1OC(=O)c2cc(C)c(Br)cc21

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 1/20 0.33
▸ CES1 P23141 1/20 0.33
▸ MAOA P21397 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26575173 1.00 BCHE (0.33) BCHECES1MAOA
SCHEMBL26125886 0.82 BCHE (0.34) BCHECES1MAOA
SCHEMBL30546103 0.78 PBRM1 (0.36) —
SCHEMBL2530842 0.78 PBRM1 (0.36) —
SCHEMBL26123449 0.73 BCHE (0.39) BCHECES1MAOA
SCHEMBL26122943 0.73 KDM4E (0.36) —
SCHEMBL30546133 0.73 KDM4E (0.36) —
SCHEMBL26124805 0.72 MAOB (0.38) —
SCHEMBL26125017 0.72 KDM4E (0.35) —
SCHEMBL26124161 0.72 CYP19A1 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192989-A2 PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS AZKARRA THERAPEUTICS, INC. (US) 2023-10-05 — — WO disclosed
Send feedback